Bronchiectasis clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
open to eligible people ages 12 years and up
AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.
Orange, California and other locations
Our lead scientists for Bronchiectasis research studies include Timmy Cheng.
Last updated: